- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
PMCPA found Galapagos’ Jyseleca website homepage banner ‘Strength of balance’ was ambiguous and insufficiently explained, breaching Clause 6.1.…
Otsuka’s “Therapy Areas in Europe” webpage still referenced working with partner Akebia on CKD anaemia after the agreement…
Novo Nordisk was ruled in breach for failures to disclose, late disclosure, and inaccurate/misplaced reporting of transfers of…
A pharmacist challenged comparative efficacy and tolerability claims for Versatis versus pregabalin/gabapentin. The Panel found interim data and…
Merz’s exhibition claim that Xeomin was “at least as effective as Botox” was ruled misleading because the cited…
A palliative medicine consultant complained about an Actiq rep’s comments on competitor Abstral. The Panel found misleading/disparaging competitor…
A health professional alleged a rep used delivery of an attendance certificate to secure a follow-up meeting (Clause…
At a Parkinson’s congress, an HCP symposium invite went into patient bags and a stand promoted “slowing clinical…
PMCPA case AUTH/3089/9/18 (Director v Merck Serono) concerned clinical trial disclosure. Under the 2016 ABPI Code it was…
Anonymous complaint alleged Roche pressured a hospital pharmacist to continue an RA project and provided drinks/money. Panel found…
One real case. One key lesson. Every week — free.